featured
Glimepiride Use Reduces the Risk of Cardiovascular Mortality in Patients With Type 2 Diabetes and Chronic Heart Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Preventive Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Glimepiride Use is Associated with Reduced Cardiovascular Mortality in Patients with Type 2 Diabetes and Chronic Heart Failure: A Prospective Cohort Study
Eur J Prev Cardiol 2022 Dec 27;[EPub Ahead of Print], W He, G Yuan, Y Han, Y Yan, G Li, C Zhao, J Shen, X Jiang, C Chen, L Ni, DW WangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.